Key Points Axsome Therapeutics has launched exciting new drugs over the past year, and they are delivering growth. The biopharma player’s late-stage pipeline could translate into additional products over the next few years. 10 stocks we like better than Axsome Therapeutics › Axsome Therapeutics (NASDAQ:AXSM) has seen its stock price climb over the past few years -- and for good reason. The company has progressively launched new products, confirming its expertise in the neuroscience space. This biotech aims to treat a variety of conditions linked to central nervous system (CNS) operations, from depression to migraine and narcolepsy.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。